Cancer Registry Data Linkage of Electronic Health Record Data From ASCO's CancerLinQ: Evaluation of Advantages, Limitations, and Lessons Learned.

MLA

Charlton, Mary E., et al. “Cancer Registry Data Linkage of Electronic Health Record Data From ASCO’s CancerLinQ: Evaluation of Advantages, Limitations, and Lessons Learned.” JCO Precision Oncology, vol. 6, Apr. 2022, pp. 1–11. EBSCOhost, https://doi.org/10.1200/CCI.21.00149.

APA

Charlton, M. E., Kahl, A. R., McDowell, B. D., Miller, R. S., Komatsoulis, G., Koskimaki, J. E., Rivera, D. R., & Cronin, K. A. (2022). Cancer Registry Data Linkage of Electronic Health Record Data From ASCO’s CancerLinQ: Evaluation of Advantages, Limitations, and Lessons Learned. JCO Precision Oncology, 6, 1–11. https://doi.org/10.1200/CCI.21.00149

Chicago

Charlton, Mary E., Amanda R. Kahl, Bradley D. McDowell, Robert S. Miller, George Komatsoulis, Jacob E. Koskimaki, Donna R. Rivera, and Kathleen A. Cronin. 2022. “Cancer Registry Data Linkage of Electronic Health Record Data From ASCO’s CancerLinQ: Evaluation of Advantages, Limitations, and Lessons Learned.” JCO Precision Oncology 6 (April): 1–11. doi:10.1200/CCI.21.00149.